Working with our members, Cancer52 has looked at the progress that has been made for people with rare and less common cancers against the NHS Long Term Plan since it was published just over a year ago. Our findings and recommendations are published in our report Getting a better deal for rare and less common cancers: One year on from the NHS Long Term Plan.

The work to inform, and the drafting of, this report was undertaken bef...

Cancer52 and PHE/NCRAS are delighted to be able to share a film and a report of the very successful Developments in Data for Rare and Less Common Cancers event held on 22nd May 2019.

The report provides a written overview of the whole event and the film includes snippets from several of the event speakers talking about their work and what they hope it will achieve for people with rare and less common cancers.

Click here to read...

On Wednesday 10th July we launched a new report, ‘Getting a better deal for people with rare and less common cancers: what we can learn from patients’ at an event for MPs at Portcullis House, Houses of Parliament. 

The report was based on a patient survey conducted in 2018. Over 670 people told us about their experiences of having a rare or less common cancer.  Three patients, Roy, Liz and Steve share their stories in the repor...

This is an ambitious plan by NHS England to move more care into the community and out of hospital, accompanied by increased funding for primary and community care, as well as continuing the trend of greater integration of services.

The cancer commitments are relatively few but hearteningly take an ‘all cancer’ approach, which by definition includes rare and less common cancers, instead of previous approaches, which have sometim...

As the NHS Long Term Plan is published - some messages of hope from people with rare and less common cancer for 2019 and beyond …. a short film made by Cancer52 at Britain Against Cancer, December 2018.

With thanks to all the patients, carers and support group charities who took part, and Cancer Minister Steve Brine MP for his input and support.

Click here to view film

Cancer52, together with use MY data, have jointly produced a briefing document on what The National Data Opt-out means for cancer patients.

Visit the joint Cancer52 and use MY data ‘Patient and Carer Voice’ stand at the Britain Against Cancer 2018 conference on Tuesday 4 December, at Central Hall Westminster, to find out more.

We are delighted that Cancer52 features in this month's New Statesman's Oncology Supplement, published to coincide with this year's Britain Against Cancer conference.

The supplement features articles from Cally Palmer, National Cancer Director at NHS England, Lynda Thomas, Chief Executive at Macmillan Cancer Support and Nic Dakin, Chair of the All Party Parliamentary Group on Cancer.

The Cancer52 section appears on p15 of the su...